Glucagon-Like Peptide-1 (GLP-1) is a hormone integral to the regulation of insulin and glucose metabolism, and it is utilized in the treatment of type 2 diabetes and obesity (Zheng et al., 2024). Here, GCG is linked to obesity disorder.